Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease

Neuroscience Letters

Volumn 270, Issue 3, 1999, Pages 129-132

  Licastro, Federico ^a   Pedrini, Steve ^a   Govoni, Marzia ^a   Pession, Annalisa ^a   Ferri, Cinzia ^b   Annoni, Giorgio ^c   Casadei, Valeria ^b   Veglia, Fabrizio ^b   Bertolini, Stefano ^d   Grimaldi, Luigi M E ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

1 Antichymotrypsin; Apolipoprotein E; Genetic polymorphism and Alzheimer disease risk

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 0033529913     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00468-1     Document Type: Article

References (19)

1. Abraham C. The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury. Res. Immunol. 143:1992;631-636.
2. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Corinne L., Han S.W., Morris J.C., Frank A., Vasquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
3. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R (3rd revised edn.), American Psychiatric Association, Washington, D.C., 1987.
4. Fraser P.E., Nguyen J.T., McLachlan D.R., Abraham C.R., Kirschner D.A. Alpha-1-antichymotrypsin binding to Alzheimer Aβ peptide is sequence specific and induces fibfil disaggregation in vitro. J. Neurochem. 61:1993;298-305.
5. Haines J.L., Prochard M.L., Saunders A.M., Schildkraut J.M., Growdon J.H., Gaskell P.C., Ferrer L.A., Auerbach S.A., Gusella J.F., Locke P.A., Rosi B.L., Yamaoka L., Small G.W., Conneally P.M., Roses A.D., Pericak-Vance M.A. No genetic effect of alpha-1-antichymotrypsin in Alzheimer disease. Genomics. 33:1996;53-56.
6. Kamboh M.I., Aston C.E., Hamman R.F. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 112:1995;145-159.
7. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE*4-associated Alzheimer's disease risk is modified by alpha-1-antichymotrypsin polymorphism. Nat. Genet. 10:1995;486-488.
8. Licastro F., Parnetti L., Morini M.C., Davis L.J., Cucinotta D., Gaiti A., Senin U. Acute phase reactant alpha-1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer's disease. Alz. Dis. Assoc. Disord. 9:1995;112-118.
9. Licastro F., Mallory M., Hansen L.A., Masliah E. Increased levels of α-1-antichymotrypsin in brain of patients with Alzheimer's disease correlated with activated astrocytes and are affected by APOE 4 genotype. J. Neuroimmunol. 88:1998;105-110.
10. Ma J., Yee A., Brewer H.B., Das S., Potter H. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
11. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
12. Mckhann G., Drachman D., Folstein M., Katzman R., Proce D., Stadlan E.R. Clinical diagnosis of Alzheimer's disease. Neurology. 34:1984;939-944.
13. Morris J.A., Gardner M.J. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br. Med. J. 296:1988;1313-1316.
14. Murphy G.M., Sullivan E.V., Gallagher-Thompson D., Thompson L.W., van Duijn C.M., Forno L.S., Ellis W.G., Jagust W.J., Yesavage J., Tinklenberg J.R. No association between the α-1-antichymotrypsin A allele and Alzheimer's disease. Neurology. 19:1997;1313-1316.
15. Nacmias B., Tedde A., Latorraca S., Piacentini S., Bracco L., Amaducci L., Guarnieri B.M., Petruzzi C., Ortenzi L., Sorbi S. Apolipoprotein E and α-1-antichymotrypsin polymorphism in Alzheimer's disease. Ann. Neurol. 40:1996;678-680.
16. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
17. Rubinsztein D.C. The genetics of Alzheimer's disease. Prog. Neurolbiol. 52:1997;447-454.
18. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid (peptide: isoform-specific effects and implication for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
19. Travis J., Salvelsen G.S. Human plasma proteinase inhibitor. Annu. Rev. Biochem. 52:1983;655-709.